Ignite Creation Date:
2025-12-25 @ 2:09 AM
Ignite Modification Date:
2025-12-31 @ 12:58 PM
Study NCT ID:
NCT01140360
Status:
COMPLETED
Last Update Posted:
2017-07-02
First Post:
2010-06-08
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Pilot Study of Gleevec/Imatinib Mesylate (STI-571, NSC 716051) in Neurofibromatosis (NF1) Patient With Plexiform Neurofibromas
Sponsor:
Kent Robertson
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-02
Start Date Type:
None
Primary Completion Date:
2016-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-12
Completion Date Type:
ACTUAL
First Submit Date:
2010-06-08
First Submit QC Date:
None
Study First Post Date:
2010-06-09
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2016-12-21
Results First Submit QC Date:
None
Results First Post Date:
2017-07-02
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-06-02
Last Update Post Date:
2017-07-02
Last Update Post Date Type:
ACTUAL